Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Genmab A (GMAB) Short-term Investments: 2018-2021

  • Genmab A's Short-term Investments fell 183.50% to -$879.9 million in Q2 2021 from the same period last year, while for Jun 2021 it was -$879.9 million, marking a year-over-year decrease of 183.50%. This contributed to the annual value of -$1.4 billion for FY2020, which is 138.60% down from last year.
  • As of Q2 2021, Genmab A's Short-term Investments stood at -$879.9 million, which was up 38.99% from -$1.4 billion recorded in Q4 2020.
  • Genmab A's Short-term Investments' 5-year high stood at -$234.65 during Q2 2019, with a 5-year trough of -$1.4 billion in Q4 2020.
  • Over the past 3 years, Genmab A's median Short-term Investments value was -$604.4 million (recorded in 2019), while the average stood at -$647.4 million.
  • Data for Genmab A's Short-term Investments shows a maximum YoY plummeted of 132,271,518.55% (in 2020) over the last 5 years.
  • Genmab A's Short-term Investments (Quarterly) stood at -$389.3 million in 2018, then slumped by 55.26% to -$604.4 million in 2019, then slumped by 138.60% to -$1.4 billion in 2020, then plummeted by 183.50% to -$879.9 million in 2021.
  • Its Short-term Investments was -$879.9 million in Q2 2021, compared to -$1.4 billion in Q4 2020 and -$310.4 million in Q2 2020.